Kouji Hattori

2.8k citations

63 papers · 2.3k indexed · 1 hit paper · h-index 24

Organic Chemistry top 2%
- Asymmetric Synthesis and Catalysis 7
- Synthesis of β-Lactam Compounds 6
Immunology top 5%
Oncology top 10%
- PARP inhibition in cancer therapy 9
Inorganic Chemistry top 5%
- Asymmetric Hydrogenation and Catalysis 5
Molecular Biology top 10%
- Receptor Mechanisms and Signaling 8
Pharmacology
- Inflammatory mediators and NSAID effects 7
Neurology
- Intracranial Aneurysms: Treatment and Complications 5
Biochemistry
- Eicosanoids and Hypertension Pharmacology 4

Co-authors: Hisashi Yamamoto Akinori Iwashita Junya Ishida Hirofumi Yamamoto Nobuya Matsuoka Hiroshi Okamura K Torigoe Takanori Okura
Cited by: Organic Chemistry Immunology Oncology
Journals: Bioorganic & Medicinal Chemistry Letters (14 papers)Journal of Medicinal Chemistry (5 papers)Bioorganic & Medicinal Chemistry (4 papers)
Partner nations: Japan United States

In The Last Decade

Kouji Hattori

56 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Kouji Hattori

Since Specialization

Citations

This map shows the geographic impact of Kouji Hattori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kouji Hattori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kouji Hattori more than expected).

Fields of papers citing papers by Kouji Hattori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kouji Hattori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kouji Hattori. The network helps show where Kouji Hattori may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kouji Hattori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kouji Hattori Line = papers co-authored together Kouji Hattori links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human β3-adrenergic receptor agonists: Part IV Bioorganic & Medicinal Chemistry Letters ·Yutaka Nakajima,Carlos M. Rodriguez,Jacky Stijven,Hitoshi Hamashima,M. Ferrer Picado,Kenichi Washizuka,Minoru Sakurai,Shigeo Matsui,Rolan Rolan,Koji Ueshima,Takao Yamamoto,Nobuhiro Yamamoto,Hirofumi Ishikawa,Keiko Nakano,E. van Bochove,Gol Fakhrabadi Fereshteh,Kouji Hattori	2008	6
2	Replacing the cyclohexene-linker of FR181157 leading to novel IP receptor agonists: Orally active prostacyclin mimetics. Part 6 Bioorganic & Medicinal Chemistry Letters ·Akira Tanaka,Kouji Hattori,Jinxian Yao,Osamu Okitsu,Einat Cotter-Metzkor,Mie Nishio,Johnson OK,Noriaki Maeda,إيناس أحمد العجمي,Jiro Seki	2006	10
3	Discovery of new diphenyloxazole derivatives containing a pyrrolidine ring: Orally active prostacyclin mimetics. Part 2 Bioorganic & Medicinal Chemistry Letters ·Kouji Hattori,Osamu Okitsu,Einat Cotter-Metzkor,Jinxian Yao,Mie Nishio,西村泰典,Jiro Seki,Kazuo Sakane	2005	8
4	Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP‐ribose) polymerase‐1/2 inhibitors FEBS Letters ·Akinori Iwashita,Kouji Hattori,Hirofumi Yamamoto,Junya Ishida,Yoshiyuki Kido,Kazunori Kamijo,Kenji Murano,Hiroshi Miyake,Takayoshi Kinoshita,Masaichi Warizaya,Mitsuru Ohkubo,Nobuya Matsuoka,Seitaro Mutoh	2005	65
5	Metabolism investigation leading to novel drug design: Orally active prostacyclin mimetics. Part 4 Bioorganic & Medicinal Chemistry Letters ·Kouji Hattori,E M Reardon,Akira Tanaka,Hisashi Takasugi,Jinxian Yao,Mie Nishio,西村泰典,Jiro Seki,Kazuo Sakane	2005	2
6	Discovery of diphenylcarbamate derivatives as highly potent and selective IP receptor agonists: Orally active prostacyclin mimetics. Part 3 Bioorganic & Medicinal Chemistry Letters ·Kouji Hattori,Akira Tanaka,Osamu Okitsu,Einat Cotter-Metzkor,Jinxian Yao,Mie Nishio,西村泰典,Mari KURANAGA,Jiro Seki,Kazuo Sakane	2005	14
7	A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice Journal of Pharmacology and Experimental Therapeutics ·Akinori Iwashita,Kayoko Mihara,Celso Luiz Azevedo Martins,Rasha Mohammed Bahaa Eldin,Junya Ishida,Hirofumi Yamamoto,Kouji Hattori,Nobuya Matsuoka,Seitaro Mutoh	2004	32
8	A Novel and Potent Poly(ADP-Ribose) Polymerase-1 Inhibitor, FR247304 (5-Chloro-2-[3-(4-phenyl-3,6-dihydro-1(2 H)-pyridinyl)propyl]-4(3 H)-quinazolinone), Attenuates Neuronal Damage in in Vitro and in Vivo Models of Cerebral Ischemia Journal of Pharmacology and Experimental Therapeutics ·Akinori Iwashita,Ali Osman Inan,Rasha Mohammed Bahaa Eldin,Celso Luiz Azevedo Martins,Kazunori Kamijo,Junya Ishida,Hirofumi Yamamoto,Kouji Hattori,Nobuya Matsuoka,Seitaro Mutoh	2004	66
9	Feasibility of Photocrosslinkable Chitosan as an Embolization Material for Aneurysms Interventional Neuroradiology ·Aarti Dubey,Takao Kojima,Kouji Hattori,Shigeru Miyachi,Masayuki Ishihara,Nozomu Kobayashi,A.S. Yudina,Sheena Geoghegan	2004	2
10	Neuroprotective Effects of a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, 2-{3-[4-(4-Chlorophenyl)-1-piperazinyl] propyl}-4(3 H)-quinazolinone (FR255595), in an in Vitro Model of Cell Death and in Mouse 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Parkinson’s Disease Journal of Pharmacology and Experimental Therapeutics ·Akinori Iwashita,Celso Luiz Azevedo Martins,Kayoko Mihara,Kouji Hattori,Hirofumi Yamamoto,Junya Ishida,Nobuya Matsuoka,Seitaro Mutoh	2004	55
11	Inhibitor‐induced structural change of the active site of human poly(ADP‐ribose) polymerase FEBS Letters ·Takayoshi Kinoshita,Isao Nakanishi,Masaichi Warizaya,Akinori Iwashita,Yoshiyuki Kido,Kouji Hattori,Takashi Fujii	2003	82
12	A simple stereoselective synthesis and biological evaluation of FR181157: orally active prostacyclin mimetic Bioorganic & Medicinal Chemistry Letters ·Kouji Hattori,Einat Cotter-Metzkor,Osamu Okitsu,Jinxian Yao	2003	6
13	Structure and function of a novel coliphage-associated sialidase FEMS Microbiology Letters ·Yuichi Machida,Katsuhide Miyake,Kouji Hattori,Shin Yamamoto,Mitsuo Kawase,Shinji Iijima	2000	22
14	Molecular cloning and characterization of a novel bacteriophage-associated sialidase Journal of Bioscience and Bioengineering ·Yuichi Machida,Kouji Hattori,Katsuhide Miyake,Yuji Kawase,Mitsuo Kawase,Shinji Iijima	2000	10
15	Development of an Intraoperative Automatic Head Shaking System for Irrigating Aneurysmal Subarachnoid Hemorrhages Japanese Journal of Neurosurgery ·Alice Nayara Alves da Silva Santos,Naohito Yamamoto,Kouji Hattori,Takeshi Okada,Masato Shibuya,Takayuki Ishihara,Braun JM,Hongsen ZHAO	1999	0
16	Interleukin-6 and Development of Vasospasm after Subarachnoid Haemorrhage Acta Neurochirurgica ·Koji Osuka,Yasuhíro Suzuki,Alice Nayara Alves da Silva Santos,Kouji Hattori,Naoki Yamamoto,Misako Takayasu,Masatoshi Shibuya,Junji Yoshida	1998	130
17	Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems—I. 2-alkoxymethyl derivatives Bioorganic & Medicinal Chemistry ·Y. Gao,David Nicklin,Keiji Matsuda,David G. Barrett,Kouji Hattori,Takashi Nakajima,Franka Reidelbach,Toshiaki Kamimura,Masayoshi Murata	1997	9
18	A Case of Neutropenic Enterocolitis Following Aplastic Anemia. The Japanese Journal of Gastroenterological Surgery ·Masami Mitani,Yoshiyuki Kuwabara,Hiroyuki Kawamura,雅一米本,Kouji Hattori,Akira Masaoka	1996	0
19	A Case of Abdominal Actinomycosis with Resection of Multiple Organs. The Japanese Journal of Gastroenterological Surgery ·Hiroyuki Kawamura,Makoto Kataoka,Yoshiyuki Kuwabara,Thanh Tùng Lê,Hiroshi Iwata,Noriyuki Shinoda,Tom Oakland,雅一米本,Kouji Hattori,J. Raloff,Akira Masaoka	1993	5
20	A Surgically Trested Case of Pharyngoesophageal (Zenker's) Diverticulum. The Japanese Journal of Gastroenterological Surgery ·Hiroyuki Kawamura,Makoto Kataoka,Yoshiyuki Kuwabara,Thanh Tùng Lê,R W SMITH,Noriyuki Shinoda,Tom Oakland,雅一米本,Kouji Hattori,J. Raloff,Akira Masaoka	1993	0

About Kouji Hattori

Kouji Hattori is a scholar working on Microbiology, Organic Chemistry and Pharmacology, having authored 63 papers that have together received 2.3k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (9 papers), Receptor Mechanisms and Signaling (8 papers), Asymmetric Synthesis and Catalysis (7 papers), Inflammatory mediators and NSAID effects (7 papers), Synthesis of β-Lactam Compounds (6 papers), Intracranial Aneurysms: Treatment and Complications (5 papers), Asymmetric Hydrogenation and Catalysis (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). The work is most often cited by research in Organic Chemistry (896 citations), Immunology (522 citations) and Oncology (436 citations). Kouji Hattori has collaborated with scholars based in Japan and United States. Frequent co-authors include Hisashi Yamamoto, Akinori Iwashita, Hisashi Yamamoto, Junya Ishida, Hirofumi Yamamoto, Nobuya Matsuoka, Hiroshi Okamura, K Torigoe, Takanori Okura and Tsuyoshi Tanimoto. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Tetrahedron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact